Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/1/2025

Treatment for Depression with Loss of Appetite

Primary Treatment Approach

  • The American College of Physicians recommends selecting between cognitive behavioral therapy or second-generation antidepressants as first-line treatment for major depressive disorder, with the choice based on adverse effect profiles, cost, accessibility, and patient preferences 1, 3
  • Both cognitive behavioral therapy and second-generation antidepressants demonstrate equivalent efficacy for treatment-naïve patients with depression 1, 4

Pharmacologic Selection When Appetite Stimulation Is Needed

  • When both depression treatment and appetite stimulation are clinical goals, mirtazapine represents the optimal pharmacologic choice, as recommended by the ESPEN guidelines 5, 2
  • Mirtazapine is specifically associated with increased appetite and weight gain as consistent therapeutic effects, making it uniquely suited for patients with depression-related appetite loss 2, 5

Alternative Antidepressant Options

  • For patients where weight gain is undesirable, bupropion is the only antidepressant consistently associated with weight loss through appetite suppression, but it may exacerbate anxiety or be inappropriate for patients with bipolar disorder 4
  • Fluoxetine and sertraline are associated with short-term weight loss and long-term weight neutrality 2, 4
  • For patients with comorbid anxiety, sertraline or fluoxetine are preferred over bupropion 4
  • For older patients, preferred agents include citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, and bupropion due to better tolerability, while paroxetine and fluoxetine should be avoided due to higher rates of adverse effects 2, 4

Critical Pitfalls to Avoid

  • Do not use appetite stimulants (dronabinol, megestrol acetate) systematically for appetite loss, as evidence is very limited with weak methodology and potentially harmful side effects 6, 5
  • Avoid paroxetine and amitriptyline if weight gain beyond therapeutic appetite restoration is a concern, as these have the highest risk for excessive weight gain among their respective classes 2, 4

Treatment Duration and Follow-Up

  • Treatment for a first episode of major depression should last at least 4 months, with longer treatment beneficial for recurrent depression 4
  • Modify treatment if inadequate response occurs within 6-8 weeks of initiation, and depression treatment phases include acute (6-12 weeks), continuation (4-9 months), and maintenance (≥1 year) 4, 1, 7

Nonpharmacologic Considerations

  • Cognitive behavioral therapy remains equally effective as pharmacotherapy and should be offered as an alternative or adjunct to medication, particularly for patients preferring nonpharmacologic approaches, as recommended by the American College of Physicians 1, 3